DNMRQ — Danimer Scientific Balance Sheet
0.000.00%
- $1.18m
- $366.89m
- $46.68m
Annual balance sheet for Danimer Scientific, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.02 | 378 | 286 | 62.8 | 59.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | 8.07 | 24.6 | 24.3 | 18.9 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.078 | 402 | 340 | 125 | 108 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | 126 | 335 | 473 | 464 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 0.078 | 546 | 839 | 712 | 698 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.057 | 50.5 | 43.5 | 25.3 | 15.7 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.057 | 190 | 338 | 335 | 420 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.021 | 356 | 500 | 378 | 278 |
Total Liabilities & Shareholders' Equity | 0.078 | 546 | 839 | 712 | 698 |
Total Common Shares Outstanding |